Skip to content
2000
Volume 5, Issue 4
  • ISSN: 1573-3998
  • E-ISSN: 1875-6417

Abstract

FGF21 is a novel member of the FGFs family, is mainly expressed in liver and it functions as a potent activator of glucose uptake on adipocytes. When over expressed in transgenic mice, it protects animals from diet-induced obesity and its administration to diabetic rodents and monkeys lowers blood glucose and triglyceride levels. Recently, increased levels of FGF21 have been identified as an independent risk factor related with metabolic syndrome. A review of the relevant roles of FGF21 in metabolism is presented here.

Loading

Article metrics loading...

/content/journals/cdr/10.2174/157339909789804396
2009-11-01
2025-05-18
Loading full text...

Full text loading...

/content/journals/cdr/10.2174/157339909789804396
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test